Novo Holdings A/S - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 54 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q1 2015$8,479,000
-85.5%
231,419
-84.3%
0.72%
-84.8%
Q4 2014$58,572,000
+226.2%
1,475,000
+63.9%
4.74%
+170.6%
Q3 2014$17,955,000
+47.9%
900,0000.0%1.75%
+188.0%
Q2 2014$12,141,000
+23.9%
900,0000.0%0.61%
-0.7%
Q1 2014$9,801,000
-39.6%
900,000
-25.0%
0.61%
-49.5%
Q4 2013$16,224,0001,200,0001.21%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q4 2013
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 317,900$11,647,0004.28%
Opaleye Management Inc. 175,000$6,412,0002.98%
Graticule Asia Macro Advisors LLC 413,200$15,139,0002.02%
BB BIOTECH AG 1,477,114$54,121,0001.61%
Iguana Healthcare Management, LLC 75,000$2,748,0001.16%
Granite Point Capital Management, L.P. 79,250$2,904,0001.06%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 458,202$16,788,0000.89%
Ghost Tree Capital, LLC 130,000$4,764,0000.86%
SECTORAL ASSET MANAGEMENT INC 605,393$22,182,0000.84%
HealthCor Management, L.P. 467,200$17,118,0000.82%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders